An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells
Research Contents

An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells

＜Dissertation information＞
（1）Title：An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells?
（2）Journal：British Journal of Cancer
（3）Author：Che-Yuan Hsu, Teruki Yanagi*, Kodai Miyamoto, Satoko Otsuguro, Katsumi Maenaka, Hiroshi Nishihara, Hideki Nakamura, Kenzo Takahashi, Hideyuki Ujiie
（4）DOI :https://doi.org/10.1038/s41416-025-03016-2